✦ LIBER ✦

85. Substrate reduction therapy in the treatment of neurolipidoses: Niemann–Pick type C as a paradigm

✍ Scribed by Charles Lourenço; Jose Simon Camelo Jr; Vanessa Van der Linden; Mara Lucia Santos; Regina Albuquerque; Marlene Turcato; Erlane Ribeiro; Wilson Marques Jr

Book ID: 116988822
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 43 KB
Volume: 99
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2009.10.102

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

82. Substrate reduction therapy in Niema

82. Substrate reduction therapy in Niemann-Pick disease type C: Report of five Brazilian patients

✍ Charles Lourenco; J.S. Camelo Jr.; M.L.S.F. Santos; V. Van Der Linden; M. Turcat 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

The videofluoroscopic swallowing study s

The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann–Pick disease type C after therapy with miglustat

✍ Simona Fecarotta; Michele Amitrano; Alfonso Romano; Roberto Della Casa; Diana Br 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

A point mutation in the lariat branch po

A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease

✍ Enza Di Leo; Francesca Panico; Patrizia Tarugi; Carla Battisti; Antonio Federico 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 1 views

The lariat branch point sequence (BPS) is crucial for splicing pre-mRNA even if BPS mutations have infrequently been reported in human disease. In two siblings with Niemann-Pick type C (NPC) disease we identified two mutations of the NPC1 gene: i) one in exon 20 (c.2932C>T) (p.R978C) previously repo